Bioventus.

PositionTRIANGLE BRIEFS: DURHAM

Bioventus filed for an initial public offering, seeking to raise $182.6 million. Started in 2012, the company makes products to help patients heal from bone and joint injuries, diseases and surgeries...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT